Persistent induction of nitric oxide synthase in tumours from mice treated with the anti tumour agent 5,6-dimethylxanthenone-4-acetic acid

British Journal of Cancer

Volumn 77, Issue 3, 1998, Pages 426-433

  Moilanen, E ^a   Thomsen, L L ^a   Miles, D W ^b   Happerfield, L ^b   Knowles, R G ^a   Moncada, S ^a,c  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5,6 dimethylxanthenone 4 acetic acid; Anti tumour agent; Nitric oxide

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; ANTINEOPLASTIC AGENT; CORYNEBACTERIUM PARVUM EXTRACT; ENDOTOXIN; MURAMYL DIPEPTIDE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; COLON TUMOR; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; THYMUS; TUMOR NECROSIS; TUMOR REGRESSION;

EID: 0031973829     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.68     Document Type: Article

References (34)

1. Ching L-M, Joseph WR and Baguley BC (1992) Stimulation of macrophage tumoricidal activity by 5.6-dimethyl-xanthone-4-acetic acid, a potent analogue of the untitumor agent flavone-8-acetic acid. Biochem Pharmacol 44: 192 195
2. Ching L.-M. Joseph WR, Crosier KE and Baguley BC (1994a) Induction of tumor necrosis factor-α messenger RNA in human and murine cells by the flavone acetic acid analogue 5.6-dimethylxanthenone-4-acetic acid (NSC 640488). Cancer Res 54: 870 872
3. Ching L-M, Joseph WR, Zhuang I, and Baguley BC (1944b) Interaction between the antitumor agent 5.6-dimelhylxanthenone-4-acetic acid in the induction of tumor necrosis factor and haemorrhagic necrosis of colon 38 tumors. Cancer Chemother Pharmacol 35: 153 160
4. Cox GW, Melillo G. Chattopadhyay U. Mullet D. Fertel RH and Varesio L (1992) Tumor necrosis factor-α-dependent production of reactive nitrogen intermediates mediates IFNγ plus IL-2-induced murine macrophage tumoricidal activity. J Immunol 149: 3290-3296
5. Cunha FQ, Assreuy J, Moss DW, Rees D, Leal LMC, Moneada S, Carrier M, O'Donnell CA and Liew FY (1994) Differential induction of nitric oxide synthase in varioss organs of the mouse during endoloxaemia: role of TNF-α and IL-1-β. Immunology 81: 211-215
6. Davison W and Woof C (1978) Comparison of different forms of cadmium as reducing agents for the batch determination of nitrate. Analyst 101: 403-406
7. Deakin AM, Payne AN, Whittle BJR and Moneada S (1995) The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of 1774 cells with LPS and IFN-γ. Cytokine 7: 408-416
8. Futami H, Eader L, Back TT, Gruys E. Young HA, Wiltroot RH and Baguley BC (1992) Cytokine induction and therapeutic synergy with IL-2 against murine renal cancer by xanthenone-4-acetic acid derivatives. J Immumother 12: 247-255
9. 15N|nitrate in biological fluids. Annal Biochem 126: 131-138
10. Hibbs J, Taintor RR and Vavrin Z (1987) Macrophage cytotoxicity : role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476
11. Hibbs JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranovvski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP and Samlowski WE (1992) Evidence of cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interlenkin-2 therapy. J Clin 89: 867-877
12. Jenkins CD, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moneada S (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396
13. Kilbourn RG, Owen-Schaub LB, Cromeens DM, Gross SS, Flaherty MJ, Santee SM, Alak AM and Griffith OW (1994) N-melhyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs. J Appl Physiol 76: 1130-1137
14. Knowles RG and Moneada S (1994) Nitric oxide synthases in mammals. Biochem J 298: 249-258
15. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H and Jeanin JF (1994) Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152: 5077-5083
16. Lepoivre M, Boudbid H and Pelit J-F (1989) Antiproliferative activity of γ-interteron combined with lipopolysaccharide on murine adenocarcinoma: Dependence on an L-arginine metabolism with production of nitrite and citrulline. Cancer Res 49: 1970-1979
17. Lorsbach RB, Murphy WJ, Lowenstein CJ, Synder SH and Russell SW (1993) Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. J Biol Chem 268: 1908-1913
18. Maragos CM, Wang JM, Hrabie JA, Oppenheim JJ and Keefer LK (1993) Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res 53: 564-568
19. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Rueo L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270
20. Miles D, Thomsen L, Balkwill F, Thavasu P and Moncada S (1994) Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Invest 24: 287-290
21. Ocha JB, Curti B, Peitzman AB, Simmons RL, Billiar TR, Hoffmann R, Rault R, Longo DL, Urba WJ and Ochoa AC (1992) Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes. J Natl Cancer Inst 84: 864-867
22. Palacios M, Knowles RG and Moncada S (1992) Enhancers of nonspecific immunity induce nitric oxide synthase: induction does not correlate with toxicity or adjuvancy. Eur J Immunol 22: 2303-2307
23. Perera P-Y, Barber SA, Ching L-M and Vogel SN (1994) Activation of LPS-inducible genes by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid in primary murine macrophages. J Immunol 153: 4684-4693
24. Rees DD, Cunha FQ, Assreuy J, Herman AG and Moncada S (1995) Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br J Pharmacol 114: 689-693
25. Rewcastle GW, Atwell GJ, Zhuang L, Baguley BC and Denny WA (1991) Potential antitumor agents, 61. Structure-activation relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids. J Med Chem 34: 217-222
26. 2+-independent nitric oxide synthases. FEBS Lett 291: 145-149
27. Scheiber H and Rowley DA. (1995) The immunology of solid tumors. In Samter's Immunologic Diseases. Frank MM, Austen KF, Claman HN and Unanue ER (eds), pp. 607-622. Little, Brown: Boston
28. Thomsen LL, Ching L-M and Baguley BC (1990) Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid. Cancer Res 50: 6966-6970
29. Thomsen LL, Ching L-M, Zhuang L, Gavin JB and Baguley BC (1991 ) Tumor-dependent increased plasma nitrate concentrations as an indicator of the antitumor effect of flavone-8-acetic acid and analogues in mice. Cancer Res 51: 77-81
30. Thomsen LL, Baguley BC, Rustin GJ and O'Reilly SM (1992) Flaone acetic acid (FAA) with recomhinant interleukm-2 (IL-2) in advanced malignant melanoma. II: induclion ot nitric oxide production. Br J Cancer 66: 723-727
31. Veszelovszky E, Thomsen LL, Zhuang I, and Baguley BC (1993) Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: Relationship between plasma nitrate elevation and the induclion of tumor necrosis. Eur J Cancer 29A: 404-408
32. Xie K, Huang S, Dong Z, Juang S-H, Gutman M, Xie Q-W, Nathan C and Fidler IJ (1995a) Transfection with the inducible nitric oxide synthase gene suppresses tumorigenity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333-1343
33. Xie K, Huang S, Dong Z, Gutman M and Fidler IJ (1995b) Direct correlation between expression of endogenous nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55: 3123-3131
34. Zwi LJ, Baguley BC, Gavin JB and Wilson WR (1989) Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. J Natl Cancer Inst 81: 1005-1013